Clinical Trials Directory

Trials / Completed

CompletedNCT02127164

Vacuum Assisted Therapy in Emergent Contaminated Abdominal Surgeries

Prospective Evaluation of Wound Management Using Vacuum Assisted Instillation Therapy in Emergent Contaminated Abdominal Surgeries

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
18 (actual)
Sponsor
University of Arizona · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Emergent abdominal surgeries have very high rate of wound contamination due to exposure to bacteria from GI tract. There are several different approaches to wound management in these patients including wet-to-dry dressing or application vacuum assisted device on the wound. The investigators propose using the vacuum assisted device with Dakin's solution on patients undergoing emergency surgery for hollow viscus perforation installed immediately at the end of operation and remained there for the first 3 postoperative days, followed by delayed primary closure on postoperative day 4. The investigators believe this technique can achieve earlier wound closure, decrease patient discomfort, improve cost savings, and potentially standardize and revolutionize the investigators management of heavily contaminated wounds.

Conditions

Interventions

TypeNameDescription
DEVICE"Veraflo" device, Dakin's solutionVeraflo device will be installed on the wound to create negative pressure after surgery. Dakin's solution will be instilled through this device into the wound at the regular intervals.

Timeline

Start date
2014-05-01
Primary completion
2017-05-01
Completion
2017-06-01
First posted
2014-04-30
Last updated
2024-01-30
Results posted
2024-01-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02127164. Inclusion in this directory is not an endorsement.